BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21880575)

  • 1. Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors.
    Kimura Y; Fujita M; Hong J; Lohith TG; Gladding RL; Zoghbi SS; Tauscher JA; Goebl N; Rash KS; Chen Z; Pedregal C; Barth VN; Pike VW; Innis RB
    J Nucl Med; 2011 Oct; 52(10):1638-45. PubMed ID: 21880575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand 11C-NOP-1A.
    Lohith TG; Zoghbi SS; Morse CL; Araneta MF; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
    J Nucl Med; 2012 Mar; 53(3):385-92. PubMed ID: 22312136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.
    Lohith TG; Zoghbi SS; Morse CL; Araneta MD; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
    Neuroimage; 2014 Feb; 87():89-95. PubMed ID: 24225488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of LC-MS/MS-based receptor occupancy tracers and positron emission tomography radioligands for the nociceptin/orphanin FQ (NOP) receptor.
    Pedregal C; Joshi EM; Toledo MA; Lafuente C; Diaz N; Martinez-Grau MA; Jiménez A; Benito A; Navarro A; Chen Z; Mudra DR; Kahl SD; Rash KS; Statnick MA; Barth VN
    J Med Chem; 2012 Jun; 55(11):4955-67. PubMed ID: 22541041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain and whole-body imaging in nonhuman primates with [11C]MeS-IMPY, a candidate radioligand for beta-amyloid plaques.
    Seneca N; Cai L; Liow JS; Zoghbi SS; Gladding RL; Hong J; Pike VW; Innis RB
    Nucl Med Biol; 2007 Aug; 34(6):681-9. PubMed ID: 17707808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nociceptin Receptors Upregulated in Cocaine Use Disorder: A Positron Emission Tomography Imaging Study Using [
    Narendran R; Tollefson S; Himes ML; Paris J; Lopresti B; Ciccocioppo R; Mason NS
    Am J Psychiatry; 2019 Jun; 176(6):468-476. PubMed ID: 31055968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography.
    Pike VW; Rash KS; Chen Z; Pedregal C; Statnick MA; Kimura Y; Hong J; Zoghbi SS; Fujita M; Toledo MA; Diaz N; Gackenheimer SL; Tauscher JT; Barth VN; Innis RB
    J Med Chem; 2011 Apr; 54(8):2687-700. PubMed ID: 21438532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nociceptin Receptors in Alcohol Use Disorders: A Positron Emission Tomography Study Using [
    Narendran R; Ciccocioppo R; Lopresti B; Paris J; Himes ML; Mason NS
    Biol Psychiatry; 2018 Nov; 84(10):708-714. PubMed ID: 28711193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic brain analysis and whole-body imaging in monkey of [11C]MNPA: a dopamine agonist radioligand.
    Seneca N; Skinbjerg M; Zoghbi SS; Liow JS; Gladding RL; Hong J; Kannan P; Tuan E; Sibley DR; Halldin C; Pike VW; Innis RB
    Synapse; 2008 Sep; 62(9):700-9. PubMed ID: 18566975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET.
    McCarron JA; Zoghbi SS; Shetty HU; Vermeulen ES; Wikström HV; Ichise M; Yasuno F; Halldin C; Innis RB; Pike VW
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1670-82. PubMed ID: 17579853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of the rhesus monkey nociceptin/orphanin FQ receptor.
    Koga K; Ichikawa D; Nambu H; Azuma-Kanoh T; Sakai N; Takaki-Kawagoe H; Ozaki S; Ohta H
    Genes Genet Syst; 2009 Oct; 84(5):319-25. PubMed ID: 20154418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupancy of Nociceptin/Orphanin FQ Peptide Receptors by the Antagonist LY2940094 in Rats and Healthy Human Subjects.
    Raddad E; Chappell A; Meyer J; Wilson A; Ruegg CE; Tauscher J; Statnick MA; Barth V; Zhang X; Verfaille SJ
    Drug Metab Dispos; 2016 Sep; 44(9):1536-42. PubMed ID: 27353045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain.
    Yasuno F; Brown AK; Zoghbi SS; Krushinski JH; Chernet E; Tauscher J; Schaus JM; Phebus LA; Chesterfield AK; Felder CC; Gladding RL; Hong J; Halldin C; Pike VW; Innis RB
    Neuropsychopharmacology; 2008 Jan; 33(2):259-69. PubMed ID: 17392732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a PET Radioligand to Image
    Paul S; Haskali MB; Liow JS; Zoghbi SS; Barth VN; Kolodrubetz MC; Bond MR; Morse CL; Gladding RL; Frankland MP; Kant N; Slieker L; Shcherbinin S; Nuthall HN; Zanotti-Fregonara P; Hanover JA; Jesudason C; Pike VW; Innis RB
    J Nucl Med; 2019 Jan; 60(1):129-134. PubMed ID: 30213846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors.
    Imaizumi M; Briard E; Zoghbi SS; Gourley JP; Hong J; Fujimura Y; Pike VW; Innis RB; Fujita M
    Neuroimage; 2008 Feb; 39(3):1289-98. PubMed ID: 18024084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-blast treatment with Nociceptin/Orphanin FQ peptide (NOP) receptor antagonist reduces brain injury-induced hypoxia and signaling proteins in vestibulomotor-related brain regions.
    Awwad HO; Durand CD; Gonzalez LP; Tompkins P; Zhang Y; Lerner MR; Brackett DJ; Sherry DM; Awasthi V; Standifer KM
    Behav Brain Res; 2018 Mar; 340():183-194. PubMed ID: 27793733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of [¹⁸F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human.
    Hostetler ED; Sanabria-Bohórquez S; Eng W; Joshi AD; Patel S; Gibson RE; O'Malley S; Krause SM; Ryan C; Riffel K; Bi S; Okamoto O; Kawamoto H; Ozaki S; Ohta H; de Groot T; Bormans G; Depré M; de Hoon J; De Lepeleire I; Reynders T; Cook JJ; Burns HD; Egan M; Cho W; van Laere K; Hargreaves RJ
    Neuroimage; 2013 Mar; 68():1-10. PubMed ID: 23238431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
    Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
    Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.